Literature DB >> 31927105

Inpatient Management of Inflammatory Bowel Disease-Related Complications.

Manreet Kaur1, Robin L Dalal2, Seth Shaffer3, David A Schwartz2, David T Rubin3.   

Abstract

Despite advances in therapeutic options, a sizeable proportion of patients with inflammatory bowel disease require hospitalization or surgery during their lifetime. While current treatment guidelines for the management of ulcerative colitis and Crohn's disease cover the spectrum of disease severity and behavior, management of acute complications of inflammatory bowel disease can present unique challenges that are not always addressed in these guidelines. In this review, the authors provide a comprehensive summary of the existing literature focused on management of patients hospitalized with complications of inflammatory bowel disease. Proposed management algorithms are provided to guide clinicians through common scenarios to determine the most appropriate interventions - escalation of medical therapies, non-surgical therapeutic interventions (drainage of intra-abdominal abscess or endoscopic balloon dilation) or surgery. Prevention of complications is proposed through a multi-disciplinary approach that involves surgeons, dieticians, radiologists, pathologists and infectious disease consultants.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abscess; Acute Colitis; Hospitalization; IBD; Stricture

Mesh:

Year:  2020        PMID: 31927105     DOI: 10.1016/j.cgh.2019.12.040

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  10 in total

1.  Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.

Authors:  Sara Lewin; Fernando S Velayos
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

2.  Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Jeffrey D McCurdy; Christopher Ma; Vipul Jairath; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

Review 3.  Medical, Endoscopic and Surgical Management of Stricturing Crohn's Disease: Current Clinical Practice.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Kostas Tepelenis; George Pappas-Gogos; Konstantinos H Katsanos; Georgios D Lianos; Francesco Frattini; Konstantinos Vlachos; Dimitrios K Christodoulou
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

4.  Racial differences in the outcomes of IBD hospitalizations: a national population-based study.

Authors:  Jennifer C Asotibe; Emmanuel Akuna; Dimeji Williams; Olukayode A Busari; Ehizogie Edigin; Ikechukwu Achebe; Brenda Mishael Asotibe; William Trick; Satya Mishra
Journal:  Int J Colorectal Dis       Date:  2021-10-25       Impact factor: 2.571

Review 5.  How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.

Authors:  Júlio Maria Fonseca Chebli; Natália Sousa Freitas Queiroz; Adérson Omar Mourão Cintra Damião; Liliana Andrade Chebli; Márcia Henriques de Magalhães Costa; Rogério Serafim Parra
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

Review 6.  The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.

Authors:  Chethana Kamath; Erica J Brenner
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-04-26

7.  AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

Authors:  David T Rubin; Joseph D Feuerstein; Andrew Y Wang; Russell D Cohen
Journal:  Gastroenterology       Date:  2020-04-10       Impact factor: 22.682

Review 8.  Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.

Authors:  Melissa H Rosen; Jordan Axelrad; David Hudesman; David T Rubin; Shannon Chang
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

Review 9.  Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease.

Authors:  Muhammad Bilal; Leonardo Vieira Nunes; Marco Thúlio Saviatto Duarte; Luiz Fernando Romanholo Ferreira; Renato Nery Soriano; Hafiz M N Iqbal
Journal:  Mar Drugs       Date:  2021-03-30       Impact factor: 5.118

Review 10.  Bifidobacterium Longum: Protection against Inflammatory Bowel Disease.

Authors:  Shunyu Yao; Zixi Zhao; Weijun Wang; Xiaolu Liu
Journal:  J Immunol Res       Date:  2021-07-23       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.